Reported Nov 7, 2025 · Announced · Updated Aug 26, 2026
Fresenius Kabi USA, LLC recalls Fresenius Kabi Famotidine Injection, USP 20 mg per 2 mL due to Out-of-specification endotoxin results
Fresenius Kabi USA, LLC
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
Is this the product you have?
- Famotidine Injection
- USP 20 mg per 2 mL BrandFresenius Kabi. Drugs
Why it was recalled
Out-of-specification endotoxin results
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Fresenius Kabi USA, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.